权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Provider Support and Patient Outreach in Lung Cancer Screening

肺癌筛查中的提供者支持和患者外展

基本信息

批准号：
10446777
负责人：
RONALD E. MYERS
金额：
$ 71.31万
依托单位：
THOMAS JEFFERSON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-01 至 2027-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10446777
关键词：
Address Adoption Adult Advisory Committees Affect Age-Years Baseline Surveys Cancer Etiology Caring Cessation of life Communication Computerized Medical Record Consent Control Groups Country Data Delaware Eligibility Determination Focus Groups Guidelines Health Health Professional Health system Healthcare Systems Information Systems Intervention Interview Journals Maintenance Malignant Neoplasms Malignant neoplasm of lung Mediator of activation protein Methods Participant Patients Peer Review Pennsylvania Physicians Preventive service Primary Health Care Professional Organizations Provider Publications Randomized Reporting Schedule Site Smoke Smoking History Support Groups Surveys Telephone Testing United States United States Centers for Medicare and Medicaid Services Update Visit aged care providers cohort design implementation intervention intervention effect low dose computed tomography lung cancer screening meetings mortality patient outreach randomized trial recruit screening shared decision making symposium

项目摘要

We propose to conduct a multi-level intervention randomized trial in four health systems (Christiana Care Health System (CCHS), Jefferson Health (JH), Lehigh Valley Health Network (LVHN), and PennState Health (PSH)) to test the combined and separate effects of a provider support intervention and a patient outreach intervention on SDM and LCS in primary care practice. Using a mixed methods 2x2 factorial design, we initially will recruit and randomize 28 primary care practices and providers either to a Provider Support Group (N=14) or a Control Group (N=14). Over three years, we will also identify approximately 4,480 patients who are potentially eligible for LCS and have a scheduled primary care visit. On a weekly basis, we will allocate identified patients to cohorts and initiate telephone contact with each cohort to verify screening eligibility, obtain consent, and complete a baseline survey. We will randomize at least 672 patient participants either to a Patient Outreach Group (N=336) or a Control Group (N=336). Thus, the trial will involve a Provider Support + Patient Outreach Group, a Provider Support Group, a Patient Outreach Group, and a Control Group. We will collect health system electronic medical records (EMRs) data, study administrative data, physician and patient survey data, and interview data from physicians, practice staff, health system care coordinators, and health system leaders for use in addressing trial aims. Specific aims of the trial are as follows: Aim 1. Assess intervention impact on Lung Cancer Screening (LCS); Aim 2. Assess intervention impact on Shared Decision Making (SDM); Aim 3. Identify mediators and moderators of screening; and, Aim 4. Assess intervention implementation. We will use health system EMR data, study administrative data, provider baseline and endpoint survey data, and patient baseline and endpoint survey data, focus group data, and health system leader interview data to identify practice-, provider- and patient-level factors that impact intervention effects on screening. In terms of overall impact, this trial will identify effective strategies for increasing SDM and LCS rates in primary care and for implementing effective strategies in health systems. We will disseminate study findings through communication channels in participating health systems and more broadly by reporting results on ClinicalTrials.gov, at health care professional organization meetings, through local, state and regional conferences, and via publications in peer-reviewed journals.

我们建议在四个卫生系统（Christiana Care）中进行一项多层次干预随机试验